Interestingly, DUSP6 mRNA levels were a robust and independent predictor of outcome for adults with Philadelphia chromosome positive (Ph+) (BRC-Abl-driven) ALL, with higher than median DUSP6 mRNA levels correlating with shorter overall survival [32]. This evidence concerns the gene DUSP6 and acute lymphoblastic leukemia.